Biotechnology
615 companies in this industry
Insider Buys (30d)
51
$12.28M
Insider Sells (30d)
294
$1.03B
Top Companies by Market Cap
VRTXVertex Pharmaceuticals Incorporated
$121.16BREGNRegeneron Pharmaceuticals, Inc.
$67.58BARGXargenx SE
$45.82BRVMDRevolution Medicines, Inc.
$40.23BALNYAlnylam Pharmaceuticals, Inc.
$36.28BROIVRoivant Sciences Ltd.
$25.18BBNTXBioNTech SE
$24.56BINCYIncyte Corporation
$23.51BINSMInsmed Incorporated
$23.18BUTHRUnited Therapeutics Corporation
$22.43BRecent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | GLSI | Greenwich LifeSciences, Inc. | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Buy | 2,200 | $13.43 | $29.6K |
| Jul 30, 2026 | RLAY | Relay Therapeutics, Inc. | Bergstrom Donald A | officer: President, R&D | Sell | 2,237 | $18.61 | $41.6K |
| Jul 30, 2026 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | officer: Chief Financial Officer | Sell | 1,459 | $18.61 | $27.2K |
| Jul 30, 2026 | NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | officer: Chief Scientific Officer | Sell | 3,847 | $23.38 | $90.0K |
| Jul 30, 2026 | NRIX | Nurix Therapeutics, Inc. | van Houte Hans | officer: Chief Financial Officer | Sell | 2,845 | $23.38 | $66.5K |
| Jul 30, 2026 | CYTK | Cytokinetics, Incorporated | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 14,000 | $79.88 | $1.12M |
| Jul 30, 2026 | NBIX | Neurocrine Biosciences, Inc. | Norwalk Leslie V | director | Sell | 1,250 | $182.01 | $227.5K |
| Jul 30, 2026 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | officer: Chief Legal Officer | Sell | 3,847 | $23.38 | $90.0K |
| Jul 30, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $522.37 | $4.96M |
| Jul 30, 2026 | RLAY | Relay Therapeutics, Inc. | Rahmer Peter | officer: See remarks | Sell | 748 | $18.61 | $13.9K |
| Jul 30, 2026 | KPTI | Karyopharm Therapeutics Inc. | Poulton Stuart | officer: EVP, Chief Development Officer | Sell | 189 | $7.10 | $1.3K |
| Jul 29, 2026 | NXTC | NextCure, Inc. | ADAR1 Capital Management, LLC | 10 percent owner | Buy | 17,608 | $4.98 | $87.7K |
| Jul 29, 2026 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Faisal Ghiath | director | Buy | 95,398 | $1.05 | $100.0K |
| Jul 29, 2026 | BEAM | Beam Therapeutics Inc. | Simon Amy | officer: Chief Medical Officer | Sell | 16,667 | $25.74 | $429.0K |
| Jul 29, 2026 | VKTX | Viking Therapeutics, Inc. | Mancini Marianna | officer: Chief Operating Officer | Sell | 18,217 | $33.47 | $609.6K |
| Jul 29, 2026 | VKTX | Viking Therapeutics, Inc. | Lian Brian | director, officer: President & CEO | Sell | 148,517 | $33.32 | $4.95M |
| Jul 29, 2026 | AVTX | Avalo Therapeutics, Inc. | Doyle Mittie | officer: Chief Medical Officer | Sell | 1,000 | $20.00 | $20.0K |
| Jul 29, 2026 | GLSI | Greenwich LifeSciences, Inc. | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Buy | 1,500 | $13.62 | $20.4K |
| Jul 29, 2026 | RAPP | Rapport Therapeutics, Inc. Common Stock | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 2,210 | $42.11 | $93.1K |
| Jul 29, 2026 | DYN | Dyne Therapeutics, Inc. | Kersten Dirk | director | Sell | 261,460 | $25.51 | $6.67M |
| Jul 29, 2026 | BCDA | BioCardia, Inc. | Altman Peter | director, officer: President and CEO | Buy | 5,000 | $0.78 | $3.9K |
| Jul 29, 2026 | VKTX | Viking Therapeutics, Inc. | ZANTE GREG | officer: Chief Financial Officer | Sell | 21,217 | $33.47 | $710.1K |
| Jul 29, 2026 | EDIT | Editas Medicine, Inc. | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 4,928 | $2.67 | $13.2K |
| Jul 28, 2026 | ANIX | Anixa Biosciences, Inc. | KUMAR AMIT | director, officer: Chief Executive Officer | Buy | 5,000 | $3.44 | $17.2K |
| Jul 28, 2026 | ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 41,319 | $9.99 | $412.8K |
| Jul 28, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $526.73 | $5.00M |
| Jul 28, 2026 | ORIC | ORIC Pharmaceuticals, Inc. | Heyman Richard A. | director | Sell | 13,100 | $12.02 | $157.5K |
| Jul 28, 2026 | PCVX | Vaxcyte, Inc. | PICKERING GRANT | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 18,198 | $55.63 | $1.01M |
| Jul 27, 2026 | CYTK | Cytokinetics, Incorporated | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $80.87 | $606.5K |
| Jul 27, 2026 | OLMA | Olema Pharmaceuticals, Inc. | Harmon Cyrus | director | Sell | 25,000 | $11.65 | $291.2K |
| Jul 27, 2026 | IRD | Opus Genetics, Inc. | Magrath George | director, officer: Chief Executive Officer | Sell | 9,475 | $2.95 | $27.9K |
| Jul 27, 2026 | IRD | Opus Genetics, Inc. | SCHACHLE JOSEPH K | officer: Chief Operating Officer | Sell | 4,644 | $2.94 | $13.7K |
| Jul 27, 2026 | GLSI | Greenwich LifeSciences, Inc. | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Buy | 3,600 | $13.06 | $47.0K |
| Jul 27, 2026 | ANIX | Anixa Biosciences, Inc. | KUMAR AMIT | director, officer: Chief Executive Officer | Buy | 6,188 | $3.54 | $21.9K |
| Jul 27, 2026 | IRD | Opus Genetics, Inc. | YERXA BENJAMIN R | director, officer: President | Sell | 7,429 | $2.97 | $22.1K |
| Jul 27, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 19,000 | $531.08 | $10.09M |
| Jul 27, 2026 | IRD | Opus Genetics, Inc. | Gagnon Robert E. | officer: Chief Financial Officer | Sell | 7,783 | $2.95 | $22.9K |
| Jul 24, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $528.58 | $5.02M |
| Jul 24, 2026 | NTLA | Intellia Therapeutics, Inc. | Dulac Edward J III | officer: EVP, Chief Financial Officer | Sell | 8,111 | $11.25 | $91.2K |
| Jul 24, 2026 | DYAI | Dyadic International, Inc. | Francisco Trust under agreement dated February 28, 1996 | 10 percent owner | Sell | 95,392 | $1.31 | $125.0K |
| Jul 24, 2026 | IMVT | Immunovant, Inc. | Girao Tiago | officer: Chief Financial Officer | Sell | 6,798 | $38.69 | $263.0K |
| Jul 24, 2026 | IMVT | Immunovant, Inc. | Pande Atul | director | Sell | 1,500 | $39.80 | $59.7K |
| Jul 24, 2026 | IMVT | Immunovant, Inc. | Stout Jay S | officer: Chief Technology Officer | Sell | 2,857 | $38.69 | $110.5K |
| Jul 24, 2026 | INSM | Insmed Incorporated | Lewis William | director, officer: Chair and CEO | Sell | 10,700 | $106.06 | $1.13M |
| Jul 24, 2026 | SRZN | Surrozen, Inc. | TCG Crossover GP II, LLC | 10 percent owner | Sell | 162,500 | $21.25 | $3.45M |
| Jul 23, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $530.57 | $5.04M |
| Jul 23, 2026 | MLYS | Mineralys Therapeutics, Inc. | Warren Eric | officer: Chief Commercial Officer | Sell | 7,438 | $26.87 | $199.9K |
| Jul 23, 2026 | CYTK | Cytokinetics, Incorporated | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $80.59 | $282.1K |
| Jul 23, 2026 | RANI | Rani Therapeutics Holdings, Inc. | IMRAN MIR A | director, 10 percent owner: | Buy | 36,000 | $0.69 | $24.8K |
| Jul 23, 2026 | ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 271,108 | $9.74 | $2.64M |
Showing 1–50 of 345
1 / 7
...